Unlocking Myasthenia gravis
Join our host Professor Nils Erik Gilhus, and a panel of experts in myasthenia gravis (MG) as they discuss a range of medical and clinical challenges related to the management of MG. Coming soon - Professor Maria Teressa Ferretti will be joined by her friend and MG patient Maya Uccheddu, to discuss patient perspective and the burden of this disease. This content is intended for Healthcare Professionals only. Not intended for US audiences.
Listen on:
Episodes
Friday Jan 05, 2024
Friday Jan 05, 2024
“Changes in antibody concentrations should influence your therapeutic decision.” Professor Nils Erik Gilhus is joined by Professor Marc De Baets to discuss the importance of regularly measuring autoantibodies to support treatment decisions in people with MG.
Friday Nov 17, 2023
Friday Nov 17, 2023
Professor Nils Erik Gilhus welcomes South African neurologist Professor Jeannine Heckmann to discuss variability in MG presentation and treatment, and the impact of infections such as HIV between countries.
Friday Oct 20, 2023
Friday Oct 20, 2023
Dr Jennifer Spillane joins Professor Nils Erik Gilhus to discuss how recently launched medications targeting the pathogenic mechanisms of MG will impact management of the condition and the lives of patients.
Friday Sep 15, 2023
Friday Sep 15, 2023
Dr Maria Teresa Ferretti hosts this special podcast edition in which she is joined by Maya Uccheddu, a pharmacist who lives with MG, to hear about the patient experience from diagnosis to treatment and to discuss the patient–doctor relationship.
Thursday Jul 27, 2023
Thursday Jul 27, 2023
Professor Francesco Saccà joins Professor Nils Erik Gilhus to review sessions and research presentations focusing on MG from the European Academy of Neurology 2023 Congress, and to reflect on the congress’s key discussion points.
Thursday Jul 27, 2023
Thursday Jul 27, 2023
Professor Nils Erik Gilhus and Professor Jan De Bleecker discuss the impact of early diagnosis on patient outcomes and provide expert-led insight into the treatment options available to patients with MG based on the latest research.